Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16719,400,1.62 [1.26-2.08],0.0001721612194059
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,16853,403,0.70 [0.52-0.95],0.0199965394590861
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",AFM,Afamin,14739,343,1.78 [1.05-3.01],0.0331056117878071
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,16469,386,0.86 [0.85-0.87],1.4605621780498613e-88
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,14424,338,0.57 [0.33-0.99],0.0443943499923892
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,16566,392,1.48 [1.13-1.94],0.00462728409173
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,16897,402,0.68 [0.55-0.86],0.0011030604014131
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,16958,403,0.74 [0.56-0.99],0.0458186286084155
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,14349,335,0.72 [0.56-0.91],0.0069857424085975
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,16927,402,0.69 [0.52-0.94],0.0170518873773194
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,14239,327,0.76 [0.57-1.00],0.0498467072878566
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,14239,327,1.25 [1.25-1.25],0.0
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,14239,327,1.12 [1.01-1.23],0.0333276702876072
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,14282,332,0.77 [0.61-0.98],0.0352742638793913
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,14282,332,0.74 [0.60-0.92],0.0059013805630094
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14708,340,0.67 [0.48-0.93],0.017060079455132
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14282,332,0.76 [0.58-0.99],0.0384123381457031
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",BSG,Basigin,17009,404,1.63 [1.06-2.52],0.0256041369633461
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,16953,401,1.55 [1.05-2.29],0.0288100374666287
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14424,338,0.76 [0.57-0.99],0.0441917700277114
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",C9,Complement component C9,14728,341,0.82 [0.68-1.00],0.0459860124406231
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,16783,395,1.33 [1.02-1.75],0.0369199919277047
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,16690,400,1.16 [1.03-1.31],0.0112388431050517
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16504,386,1.34 [1.10-1.62],0.0036545023688546
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14335,334,0.78 [0.62-0.97],0.0236040034519472
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,14449,335,1.38 [1.02-1.86],0.0338907396565575
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,16876,398,0.72 [0.55-0.95],0.0189388127953606
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,16827,401,1.51 [1.09-2.09],0.0126673196691161
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,16920,400,0.79 [0.63-1.00],0.0493344495369584
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,14282,332,0.77 [0.59-0.99],0.0455362392155836
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,14449,335,1.28 [1.02-1.60],0.0328203377458246
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,16991,402,1.39 [1.11-1.76],0.0047104544469473
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16881,402,0.62 [0.44-0.87],0.0063235361585908
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,16985,405,1.28 [1.05-1.57],0.0154173272289381
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,16876,398,0.85 [0.79-0.93],0.0002684929373109
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,14424,338,0.78 [0.64-0.95],0.0138154736307423
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,16847,398,1.21 [1.00-1.45],0.0450987749830058
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,14335,334,0.64 [0.44-0.94],0.0227220677460951
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,16876,398,0.65 [0.45-0.93],0.0182951182965859
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,14708,340,0.69 [0.49-0.97],0.0335143062354766
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,16991,402,0.85 [0.75-0.98],0.0245215706395376
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,14690,342,0.73 [0.55-0.97],0.0325742336849995
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,16665,390,0.74 [0.57-0.94],0.0157706272497662
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,16860,401,0.86 [0.75-0.99],0.0309017443863972
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,16496,387,0.88 [0.78-0.99],0.0361230957721044
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,16991,402,0.88 [0.78-0.99],0.0296781833420107
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,14335,334,0.54 [0.31-0.93],0.0266064449155438
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,16504,386,0.84 [0.70-1.00],0.0497320823840005
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,14267,333,0.83 [0.72-0.96],0.0127552438975405
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,16827,401,0.87 [0.79-0.96],0.0067969434464228
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,14661,339,1.16 [1.03-1.31],0.0168533929366566
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,14688,339,0.82 [0.69-0.97],0.0241541757921044
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,17072,405,0.54 [0.32-0.92],0.0230274532835491
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,17072,405,0.76 [0.58-0.99],0.0415530383653683
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16934,404,1.28 [1.02-1.60],0.0321956174392103
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,14282,332,0.67 [0.46-0.97],0.0319932968416527
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,16474,390,1.16 [1.04-1.30],0.0104972829554751
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16827,401,1.16 [1.04-1.30],0.008477232330622
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",17072,405,0.80 [0.68-0.94],0.0051656996537267
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,17035,405,0.79 [0.63-0.99],0.0397142736000159
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,16815,399,0.78 [0.64-0.95],0.0147867426292145
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,16924,399,0.68 [0.52-0.88],0.0039594621903916
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,14739,343,1.48 [1.00-2.18],0.0492267993725627
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",FURIN,Furin,16924,399,0.68 [0.52-0.89],0.0057146794215583
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,14335,334,0.80 [0.65-0.98],0.0280164566220772
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",14644,339,0.62 [0.40-0.95],0.0287792660075861
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16781,400,1.35 [1.06-1.71],0.0141237570134668
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,16504,386,0.72 [0.56-0.92],0.0099311267852148
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,14267,333,0.85 [0.72-1.00],0.0444051092985236
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,16670,394,0.59 [0.39-0.90],0.014566485495911
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,16423,392,1.10 [1.02-1.20],0.0207717720630363
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,16496,391,0.82 [0.69-0.97],0.0210395149907687
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,17033,404,1.21 [1.00-1.46],0.0455475018959347
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,16876,398,0.59 [0.44-0.78],0.0002407134266081
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,16566,392,1.37 [1.04-1.81],0.025140139986704
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,17016,400,0.80 [0.65-0.97],0.0253351054892212
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16783,395,1.33 [1.08-1.64],0.0062881525944299
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,14724,343,1.08 [1.01-1.15],0.0185743801414504
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",16474,390,1.24 [1.05-1.46],0.0102852671996337
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14708,340,0.89 [0.79-1.00],0.0474782256914011
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,14708,340,0.76 [0.60-0.96],0.0210157060084507
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",14210,332,1.29 [1.05-1.58],0.0165673271518743
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,16881,402,0.62 [0.46-0.83],0.0014253185117583
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16719,400,0.88 [0.78-1.00],0.0494990543998477
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,14708,340,1.41 [1.00-1.97],0.0480774379772943
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,14424,338,0.63 [0.41-0.97],0.0357813358776377
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,14708,340,1.21 [1.01-1.44],0.0337915276085015
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,16527,387,1.27 [1.05-1.53],0.0145653152611789
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,14626,339,0.74 [0.58-0.95],0.0177530444682435
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,14239,327,1.15 [1.00-1.32],0.0440991968431055
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,16876,398,0.82 [0.67-1.00],0.046768096256578
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14647,339,1.33 [1.33-1.33],0.0
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,14282,332,0.64 [0.44-0.92],0.01669060800603
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,14210,332,1.27 [1.04-1.56],0.0219672707199391
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14688,339,0.81 [0.67-0.97],0.0193389288595559
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",16474,390,1.22 [1.04-1.43],0.0153396885690034
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,16827,401,1.23 [1.05-1.44],0.010251179762578
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,16924,399,0.81 [0.68-0.96],0.0130143425607404
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,16982,404,1.53 [1.06-2.23],0.0250889893972209
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,14424,338,0.58 [0.37-0.91],0.0181394968067341
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,16757,397,0.70 [0.50-0.97],0.0327124176354265
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,14700,343,1.24 [1.02-1.51],0.0325334364378493
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,16827,401,1.19 [1.06-1.33],0.0022370680010132
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,14349,335,1.35 [1.04-1.76],0.0261947459674014
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,14647,339,1.34 [1.09-1.64],0.0049423130468364
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PSPN,Persephin,16827,401,1.12 [1.05-1.19],0.0010879834816876
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,14349,335,1.27 [1.01-1.60],0.0379993264282724
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,14647,339,0.81 [0.67-0.98],0.0266940863120291
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16853,403,1.36 [1.03-1.78],0.029483456804809
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,16504,386,0.90 [0.82-0.99],0.0319073512699098
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,14712,343,1.92 [1.92-1.92],0.0
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,14500,335,1.54 [1.05-2.27],0.0280875456985443
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,14349,335,1.41 [1.10-1.80],0.0064704283131427
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,16566,392,1.18 [1.00-1.39],0.0438165545297917
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,14661,339,0.75 [0.59-0.95],0.0160191599146979
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,17016,400,1.37 [1.05-1.79],0.0209563604245032
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,16783,395,0.83 [0.70-0.98],0.030212453785074
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,17050,405,0.76 [0.58-0.99],0.0454852770835947
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,14335,334,1.15 [1.01-1.31],0.0323650648848166
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,14739,343,1.88 [1.16-3.05],0.010686249630551
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,14728,341,1.47 [1.01-2.16],0.0452111103468984
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,16853,403,1.50 [1.12-1.99],0.0056666726327084
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14708,340,0.75 [0.57-0.99],0.0427320520810934
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,16934,404,0.71 [0.51-0.99],0.0435304949793858
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,14335,334,0.79 [0.63-0.99],0.0437758527846414
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,14267,333,0.59 [0.40-0.87],0.0085330209729506
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,14417,333,1.18 [1.01-1.38],0.0399106229571855
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,14282,332,0.64 [0.44-0.92],0.0174741698561882
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14424,338,0.80 [0.66-0.98],0.0284699154959928
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,16995,400,1.17 [1.03-1.33],0.0145616350516677
Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,16996,403,0.68 [0.57-0.83],0.0001120166685699
